ELP5 and gallbladder cancer: The ELP5 LoF impairs the translation of hnRNPQ mRNA, a validated P53 IRES trans‐acting factor, leading to poor survival outcomes after chemotherapy treatment of gallbladder cancer (Xu et al, 2019).